PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 18 filers reported holding PTC THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $201,000 | – | 193,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 14,800,000 | $15,353,000 | 1.33% |
| WOLVERINE ASSET MANAGEMENT LLC | 25,939,000 | $26,873,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,130,000 | $24,718,000 | 0.19% |
| CSS LLC/IL | 2,000,000 | $2,072,000 | 0.12% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 9,500,000 | $9,909,000 | 0.09% |
| Allianz Asset Management GmbH | 31,695,000 | $32,786,000 | 0.03% |
| AQR Arbitrage LLC | 1,500,000 | $1,565,000 | 0.02% |
| D. E. Shaw & Co., Inc. | 9,443,000 | $9,776,000 | 0.01% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 9,300,000 | $9,677,487,000 | 0.01% |
| Citadel Advisors | 13,000,000 | $13,479,000 | 0.01% |